Reduced Expression of Chemerin in Visceral Adipose Tissue Associates with Hepatic Steatosis in Patients with Obesity

Bekaert Marlies; Ouwens D. Margriet; Hoerbelt Tina; Van de Velde Frederique; Fahlbusch Pia; de Wiza Daniella Herzfeld; Van Nieuwenhove Yves; Calders Patrick; Praet Marleen; Hoorens Anne; Geerts Anja; Verhelst Xavier; Kaufman Jean-Marc; Lapauw Bruno

首页> 外文期刊>Obesity >Reduced Expression of Chemerin in Visceral Adipose Tissue Associates with Hepatic Steatosis in Patients with Obesity

【24h】

Reduced Expression of Chemerin in Visceral Adipose Tissue Associates with Hepatic Steatosis in Patients with Obesity

机译：肥胖患者内脏脂肪组织伴肝脂肪变性中chemerin的表达降低

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: This study aimed to evaluate whether circulating levels and/or visceral adipose tissue (VAT) expression of recently described adipokines associate with histopathological severity of nonalcoholic fatty liver disease (NAFLD), independent of obesity and insulin resistance.

机译：目的：本研究旨在评估最近描述的脂肪因子的循环水平和/或内脏脂肪组织（VAT）表达是否与非酒精性脂肪肝疾病（NAFLD）的组织病理学严重性相关，而与肥胖和胰岛素抵抗无关。

著录项

来源
《Obesity 》 |2016年第12期| 共9页
作者
Bekaert Marlies; Ouwens D. Margriet; Hoerbelt Tina; Van de Velde Frederique; Fahlbusch Pia; de Wiza Daniella Herzfeld; Van Nieuwenhove Yves; Calders Patrick; Praet Marleen; Hoorens Anne; Geerts Anja; Verhelst Xavier; Kaufman Jean-Marc; Lapauw Bruno;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病 ;
关键词

相似文献

外文文献
中文文献
专利

1. Reduced Expression of Chemerin in Visceral Adipose Tissue Associates with Hepatic Steatosis in Patients with Obesity [J] . Bekaert Marlies, Ouwens D. Margriet, Hoerbelt Tina, Obesity . 2016 ,第12期

机译：肥胖患者内脏脂肪组织伴肝脂肪变性中chemerin的表达降低
2. Erratum to: SIRT1 Transcription Is Decreased in Visceral Adipose Tissue of Morbidly Obese Patients with Severe Hepatic Steatosis [J] . Cíntia dos Santos Costa, Thais Ortiz Hammes, Francieli Rohden, Obesity Surgery . 2010 ,第6期

机译：勘误到：严重肝脂肪变性的病态肥胖患者的内脏脂肪组织中的SIRT1转录减少
3. SIRT1 transcription is decreased in visceral adipose tissue of morbidly obese patients with severe hepatic steatosis. [J] . Costa Cdos S, Hammes TO, Rohden F, Obesity surgery . 2010 ,第5期

机译：在患有严重肝脂肪变性的病态肥胖患者的内脏脂肪组织中，SIRT1转录降低。
4. Visceral adipose tissue macrophage-targeted gene delivery for treating obesity-induced type Ⅱ diabetes [C] . Yoonsung Song, Seok-Beom Yong, Hyunjoon Wee, Society for Biomaterials annual meeting and exposition . 2018

机译：内脏脂肪组织巨噬细胞靶向基因治疗肥胖引起的Ⅱ型糖尿病
5. Lipoprotein Receptor SR-B1 Deficiency Enhances Adipose Tissue Inflammation and Reduces Susceptibility to Hepatic Steatosis During Diet-Induced Obesity in Mice [D] . ?Rivera Vega, Katherine Solange 2020

机译：脂蛋白受体SR-B1缺乏增强脂肪组织炎症，并在小鼠饮食诱导的肥胖期间减少对肝脏脂肪变性的易感性
6. Osteopontin Deletion Prevents the Development of Obesity and Hepatic Steatosis via Impaired Adipose Tissue Matrix Remodeling and Reduced Inflammation and Fibrosis in Adipose Tissue and Liver in Mice [O] . Andoni Lancha, Amaia Rodríguez, Victoria Catalán, -1

机译：骨桥蛋白的缺失通过受损的脂肪组织基质重塑以及减少小鼠脂肪组织和肝脏的炎症和纤维化预防肥胖症和肝脂肪变性的发展。
7. Reduced expression of chemerin in visceral adipose tissue associates with hepatic steatosis in patients with obesity [O] . Bekaert Marlies, Ouwens Margriet, Hörbelt Tina, 2016

机译：在肥胖患者中，内脏脂肪组织中chemerin的表达降低与肝脂肪变性相关

Reduced Expression of Chemerin in Visceral Adipose Tissue Associates with Hepatic Steatosis in Patients with Obesity

摘要

著录项

相似文献

相关主题

期刊订阅